Resilience Announces Appointment of William S. Marth, RPh., MBA as Chief Executive Officer
SAN DIEGO, CA, December 5, 2024 – National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening...
NEWS
Read on
Resilience Secures Funding to Expand Domestic Manufacturing for Critical Pharmaceutical Ingredients
San Diego, CA – October 3, 2024 – National Resilience, Inc., a technology-focused biomanufacturing company dedicated to broadening access to complex...
Resilience Appoints Dr. Susan Billings, Chief Commercial Officer
SAN DIEGO, CA, September 30, 2024 – National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening...
Resilience Expands Clinical and Commercial Drug Product Manufacturing Capabilities and Capacities
$225 million to be invested into Cincinnati facility to increase PFS and Cartridge fill/finish capabilities Expanding Research Triangle Park (RTP)...
National Resilience and Taiwan Bio-Manufacturing Corporation Announce Groundbreaking Partnership in Biomanufacturing Innovation
Taipei, Taiwan and San Diego, California, February 5, 2024 – National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company...
Resilience to Present at the 42nd Annual J.P. Morgan Healthcare Conference
SAN DIEGO, CA, January 4, 2024 – National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access...
